Cargando…
Possible Pharmacological Approach Targeting Endoplasmic Reticulum Stress to Ameliorate Leptin Resistance in Obesity
Obesity is associated with metabolic syndrome, such as diabetes, hypertension, and hyperlipidemia. Therefore, drug development for the treatment of obesity is needed. Leptin is an anti-obesity hormone that inhibits food intake and increases energy metabolism, and, as such, treatments involving lepti...
Autores principales: | Hosoi, Toru, Ozawa, Koichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896911/ https://www.ncbi.nlm.nih.gov/pubmed/27375555 http://dx.doi.org/10.3389/fendo.2016.00059 |
Ejemplares similares
-
Fluvoxamine Attenuated Endoplasmic Reticulum Stress-Induced Leptin Resistance
por: Hosoi, Toru, et al.
Publicado: (2012) -
Flurbiprofen ameliorated obesity by attenuating leptin resistance induced by endoplasmic reticulum stress
por: Hosoi, Toru, et al.
Publicado: (2014) -
Homocysteine causes neuronal leptin resistance and endoplasmic reticulum stress
por: Preninka, Arini Isnani, et al.
Publicado: (2022) -
Possible Integrative Actions of Leptin and Insulin Signaling in the Hypothalamus Targeting Energy Homeostasis
por: Thon, Mina, et al.
Publicado: (2016) -
Editorial: Leptin Resistance in Metabolic Disorders: Possible Mechanisms and Treatments
por: Hosoi, Toru, et al.
Publicado: (2017)